Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...

A panelist discusses how axatilimab, a humanized IgG4 monoclonal antibody targeting CSF-1 receptors on monocytes and macrophages, showed promising results in the AGAVE-201 trial for ...

TURKU, FI / ACCESS Newswire / May 15, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Overcoming immune resistance in HR-MDS: Detailed safety and efficacy Phase II data on bexmarilimab to be ...

For dermatology patients, neighborhood-level socioeconomic status (nSES) is associated with a new diagnosis of hidradenitis ...

Scientists at the Leibniz Institute on Aging—Fritz Lipmann Institute (FLI) in Jena have discovered a previously unknown ...

TURKU, FINLAND / ACCESS Newswire / May 14, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN):Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focus ...

Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today that it will actively participate in and Toby Maher, M.D., will deliver a keynote presentation titled "SyMMPonia: A Phase 2 Study of ...

Scientists at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena discovered a previously unknown function of immune cells in the ...

Cardiovascular diseases (CVD) account for 24.8% of all deaths in India, with an age-standardized death rate of 272 per ...

Teos Therapeutics faces significant setbacks with the discontinuation of their TIGIT program and belrestotug, leaving them ...

Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising ...

Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Markets Day in Zürich . Schlieren (Zürich), Switzerland, May – Kuros B ...